Regulatory News for June 2010

Regulatory News Archive

World’s first prescription cannabis medicine launched World’s first prescription cannabis medicine launched

The UK launch of Sativex®, GW Pharmaceuticals’ oromucosal spray for the treatment of spasticity caused by multiple sclerosis, has been announced.

NICE issues first biosimilar recommendation NICE issues first biosimilar recommendation

Latest NICE cost–benefit guidance includes Sandoz’s Omnitrope® as one of seven recommended somatropin products to treat growth failure in children.

Together for rare diseases Together for rare diseases

Stakeholders celebrate ten years of success of the EU regulation on orphan medicines at the European Parliament.

New osteoporosis treatment approved for use in the UK New osteoporosis treatment approved for use in the UK

Amgen announced recently that Prolia (denosumab), a new type of osteoporosis treatment for post-menopausal women, has been granted marketing authorization in the UK.